Download PDF
Semin Thromb Hemost 2016; 42(04): 375-380
DOI: 10.1055/s-0036-1572325
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Fibrinogen Concentrates for Acquired Fibrinogen Deficiencies?

Charles Marc Samama
1   Department of Anaesthesia and Intensive Care Medicine, Cochin and Hôtel-Dieu University Hospitals, Paris, France
› Author Affiliations
Further Information

Publication History

Publication Date:
07 April 2016 (online)

    Permissions and Reprints

Abstract

Surgical bleeding has been decreasing steadily for the last 20 years, but there are still some hemorrhagic procedures occurring in scheduled surgical settings and emergency procedures. The interest in potent hemostatic agents has recently focused on fibrinogen concentrates. A weak historical rationale based on the rapid decrease in fibrinogen concentration in the bleeding patient and several uncontrolled studies have prompted the use of fibrinogen concentrates in emergency units and in operating theaters. Very few positive randomized studies are available to confirm the usefulness of fibrinogen concentrates. The largest most recent double-blind studies are even negative. As recent guidelines recommend early and liberal use of fibrinogen concentrates in massive bleeding patients, this review reports the most important facts and studies on efficacy and raises some questions about safety.

Keywords

fibrinogen concentrates - bleeding - transfusion - thrombosis
 

  • References

  • 1 Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 1987; 2 (8571) 1289-1291
    PubMedGoogle Scholar
  • 2 Mangano DT, Tudor IC, Dietzel C ; Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006; 354 (4) 353-365
    CrossrefPubMedGoogle Scholar
  • 3 Fergusson DA, Hébert PC, Mazer CD , et al; BART Investigators. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358 (22) 2319-2331
    CrossrefPubMedGoogle Scholar
  • 4 Martinowitz U, Kenet G, Segal E , et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001; 51 (3) 431-438 , discussion 438–439
    CrossrefPubMedGoogle Scholar
  • 5 Boffard KD, Riou B, Warren B , et al; NovoSeven Trauma Study Group. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005; 59 (1) 8-15 , discussion 15–18
    CrossrefPubMedGoogle Scholar
  • 6 Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010; 363 (19) 1791-1800
    CrossrefPubMedGoogle Scholar
  • 7 Hiippala ST, Myllylä GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81 (2) 360-365
    CrossrefPubMedGoogle Scholar
  • 8 Charbit B, Mandelbrot L, Samain E , et al; PPH Study Group. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007; 5 (2) 266-273
    CrossrefPubMedGoogle Scholar
  • 9 Karlsson O, Jeppsson A, Thornemo M, Lafrenz H, Rådström M, Hellgren M. Fibrinogen plasma concentration before delivery is not associated with postpartum haemorrhage: a prospective observational study. Br J Anaesth 2015; 115 (1) 99-104
    CrossrefPubMedGoogle Scholar
  • 10 Rourke C, Curry N, Khan S , et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012; 10 (7) 1342-1351
    CrossrefPubMedGoogle Scholar
  • 11 Meyer MAS, Ostrowski SR, Sørensen AM , et al. Fibrinogen in trauma, an evaluation of thrombelastography and rotational thromboelastometry fibrinogen assays. J Surg Res 2015; 194 (2) 581-590
    CrossrefPubMedGoogle Scholar
  • 12 Waldén K, Jeppsson A, Nasic S, Backlund E, Karlsson M. Low preoperative fibrinogen plasma concentration is associated with excessive bleeding after cardiac operations. Ann Thorac Surg 2014; 97 (4) 1199-1206
    CrossrefPubMedGoogle Scholar
  • 13 Yang L, Vuylsteke A, Gerrard C, Besser M, Baglin T. Postoperative fibrinogen level is associated with postoperative bleeding following cardiothoracic surgery and the effect of fibrinogen replacement therapy remains uncertain. J Thromb Haemost 2013; 11 (8) 1519-1526
    CrossrefPubMedGoogle Scholar
  • 14 Carling MS, Jeppsson A, Wessberg P, Henriksson A, Baghaei F, Brisby H. Preoperative fibrinogen plasma concentration is associated with perioperative bleeding and transfusion requirements in scoliosis surgery. Spine 2011; 36 (7) 549-555
    CrossrefPubMedGoogle Scholar
  • 15 Groeneveld DJ, Adelmeijer J, Hugenholtz GCG, Ariëns RAS, Porte RJ, Lisman T. Ex vivo addition of fibrinogen concentrate improves fibrin network structure in plasma samples taken during liver transplantation. J Thromb Haemost 2015; (Oct) [Epub ahead of print]
    PubMedGoogle Scholar
  • 16 Fries D, Krismer A, Klingler A , et al. Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. Br J Anaesth 2005; 95 (2) 172-177
    CrossrefPubMedGoogle Scholar
  • 17 Grottke O, Braunschweig T, Henzler D, Coburn M, Tolba R, Rossaint R. Effects of different fibrinogen concentrations on blood loss and coagulation parameters in a pig model of coagulopathy with blunt liver injury. Crit Care 2010; 14 (2) R62
    CrossrefPubMedGoogle Scholar
  • 18 Zentai C, Braunschweig T, Schnabel J, Rose M, Rossaint R, Grottke O. Fibrinogen concentrate does not suppress endogenous fibrinogen synthesis in a 24-hour porcine trauma model. Anesthesiology 2014; 121 (4) 753-764
    CrossrefPubMedGoogle Scholar
  • 19 Martini WZ, Dubick MA. Fibrinogen concentrate administration inhibits endogenous fibrinogen synthesis in pigs after traumatic hemorrhage. J Trauma Acute Care Surg 2015; 79 (4) 540-547 , discussion 547–548
    CrossrefPubMedGoogle Scholar
  • 20 Hannon M, Quail J, Johnson M , et al. Fibrinogen and prothrombin complex concentrate in trauma coagulopathy. J Surg Res 2015; 196 (2) 368-372
    CrossrefPubMedGoogle Scholar
  • 21 Martin A-C, Le Bonniec B, Fischer A-M , et al. Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis. Int J Cardiol 2013; 168 (4) 4228-4233
    CrossrefPubMedGoogle Scholar
  • 22 Machlus KR, Cardenas JC, Church FC, Wolberg AS. Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice. Blood 2011; 117 (18) 4953-4963
    CrossrefPubMedGoogle Scholar
  • 23 Schöchl H, Nienaber U, Hofer G , et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14 (2) R55
    CrossrefPubMedGoogle Scholar
  • 24 Tanaka KA, Egan K, Szlam F , et al. Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion. Transfusion 2014; 54 (1) 109-118
    CrossrefPubMedGoogle Scholar
  • 25 Karlsson M, Ternström L, Hyllner M , et al. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost 2009; 102 (1) 137-144
    PubMedGoogle Scholar
  • 26 Jeppsson A, Waldén K, Roman-Emanuel C, Thimour-Bergström L, Karlsson M. Preoperative supplementation with fibrinogen concentrate in cardiac surgery: A randomized controlled study. Br J Anaesth 2015; (Nov):aev367 [Epub ahead of print]
    PubMedGoogle Scholar
  • 27 Rahe-Meyer N, Solomon C, Hanke A , et al. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology 2013; 118 (1) 40-50
    CrossrefPubMedGoogle Scholar
  • 28 Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A ; Surgical Clinical Outcome REsearch (SCORE) Group. Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. J Am Heart Assoc 2015; 4 (6) e002066-e002066
    CrossrefPubMedGoogle Scholar
  • 29 Fenger-Eriksen C, Jensen TM, Kristensen BS , et al. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost 2009; 7 (5) 795-802
    CrossrefPubMedGoogle Scholar
  • 30 Wikkelsø AJ, Edwards HM, Afshari A , et al; FIB-PPH trial group. Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial. Br J Anaesth 2015; 114 (4) 623-633
    CrossrefPubMedGoogle Scholar
  • 31 Haas T, Spielmann N, Restin T , et al. Higher fibrinogen concentrations for reduction of transfusion requirements during major paediatric surgery: A prospective randomised controlled trial. Br J Anaesth 2015; 115 (2) 234-243
    CrossrefPubMedGoogle Scholar
  • 32 Kozek-Langenecker SA, Afshari A, Albaladejo P , et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30 (6) 270-382
    CrossrefPubMedGoogle Scholar
  • 33 Spahn DR, Bouillon B, Cerny V , et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013; 17 (2) R76
    CrossrefPubMedGoogle Scholar
  • 34 Wikkelsø A, Lunde J, Johansen M , et al. Fibrinogen concentrate in bleeding patients. In: Wikkelsø A, ed. Cochrane Database Syst Rev. 2013. 8:CD008864.
    CrossrefGoogle Scholar
  • 35 Lunde J, Stensballe J, Wikkelsø A, Johansen M, Afshari A. Fibrinogen concentrate for bleeding—a systematic review. Acta Anaesthesiol Scand 2014; 58 (9) 1061-1074
    CrossrefPubMedGoogle Scholar
  • 36 Danesh J, Lewington S, Thompson SG , et al; Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005; 294 (14) 1799-1809
    CrossrefPubMedGoogle Scholar